SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, attributed to stronger demand for Amtagvi and Proleukin, is driving the rally and bullish reaction. Traders are also focused on anticipated lung cancer data, while short-squeeze and takeover talk remains speculative.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as long-term Treasury yields surge amid persistent inflation concerns, heavy government borrowing, and expectations that rates will stay higher or rise further. Traders are split between viewing the selloff as an oversold buying opportunity and expecting further losses, while debating whether elevated yields could eventually weigh on stocks.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FHFAs move to let Fannie Mae and Freddie Mac use VantageScore alongside FICO is driving concern that competition could weaken FICOs mortgage-scoring dominance and pricing power. Traders are divided between viewing the selloff as an overreaction and expecting further pressure from market-share and pricing risks.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for a U.S. Army program to develop next-generation silicon-carbide power semiconductors sparked attention, with traders viewing it as technology validation and a potential route to future defense and infrastructure opportunities. The shares sharp reversal after an initial pop fueled debate over whether the awards long-term promise outweighs the lack of disclosed contract value and near-term revenue; some traders also blamed short selling or manipulation, without evidence establishing those claims.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly earnings beat expectations, with record bookings and stronger full-year guidance driving a sharp share-price jump. Bulls are celebrating the results and demand outlook, while skeptics point to fuel-cost pressures, weaker fourth-quarter expectations and potential profit-taking after the rally.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp Treasury selloff and surging yields are dominating SPY discussion, with traders warning that higher borrowing costs and debt or inflation concerns could pressure stocks. Others point to equities resilience and possible rebounds, leaving the conversation split amid choppy trading.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Rising Treasury yields and expectations for further Fed rate hikes are weighing on rate-sensitive small caps, with traders highlighting IWMs underperformance versus large-cap tech. The conversation is split between calls for more downside and hopes that oversold conditions could support a bounce, particularly if yields and oil-related inflation pressures ease.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Jobys Texas eIPP flights, autonomous-flight demonstrations and progress toward final-stage FAA certification are drawing attention as steps toward future commercial operations. Bulls view the milestones as validation, while skeptics focus on the stocks continued weakness, cash burn, potential dilution and the uncertain certification timeline.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

Evernorths merger and planned Nasdaq listing under XRPN, alongside its proposed XRP treasury strategy, are driving attention as traders react to the registration filing and trading halts. The community is largely bullish on the potential XRP exposure and warrants, while some remain cautious about merger completion, redemptions, and valuation.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

A sharp ZBCN move has sparked breakout and altcoin-season speculation, with traders also highlighting Zebecs payroll and card products and staking rewards. Some attribute the move to a possible Robinhood connection, but that remains unconfirmed; skeptics warn that past pumps have quickly reversed and question whether adoption is translating into sustained demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?

Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders? Are SMTI, LAB, ATKR, VAL Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Sept. 11, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Proxy and Looming Shareholder Merger Vote --VRME, VAL, LAB and FTHM

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Proxy and Looming Shareholder Merger Vote --VRME, VAL, LAB and FTHM $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Proxy and Looming Shareholder Merger Vote --VRME, VAL, LAB and FTHM PR Newswire NEW YORK, Sept. 10, 2026...

INVESTOR ALERT: The M&A Class Action Firm Launches Investigation of the Merger--IRDM, VRME, VAL and LAB

INVESTOR ALERT: The M&A Class Action Firm Launches Investigation of the Merger--IRDM, VRME, VAL and LAB INVESTOR ALERT: The M&A Class Action Firm Launches Investigation of the Merger--IRDM, VRME, VAL and LAB PR Newswire NEW YORK, Sept. 8, 2026 NEW YORK, Sept. 8, 2026 /PRNewswire/ --Class Action...

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders?

Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? Are DXLG, LAB, FHB, RLYB Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 21, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--NCSM, PSBQ, LAB, and RLYB PR Newswire NEW YORK, July 20, 2026 NEW YORK, July 20, 2026 /PRNewswire...

Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders?

Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders? Are ROKU, PAYO, LAB, FOX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 15, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed...

LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the merger of Standard BioTools Inc. (NASDAQ: LAB) and Treeline Biosciences, Inc. Upon closing of the proposed transaction, Standard BioTools shareholders are expected to own approximately 16% of the combined company. Halper Sadeh...

Standard BioTools Signs Deal To Merge With Treeline Biosciences

(RTTNews) - Monday, Standard BioTools Inc. (LAB) announced an agreement with Treeline Biosciences, Inc., a clinical-stage biopharma company, to combine in an all-stock transaction...

Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates

Standard BioTools (LAB) delivered earnings and revenue surprises of 0.00% and +13.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Standard BioTools (NASDAQ:LAB) Announces Quarterly Earnings Results, Beats Expectations By $0.35 EPS

Standard BioTools (NASDAQ:LAB - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus...

Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in Boston, MA.

Standard BioTools Inc

Neutral Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.02	--	--	N/A
Q2 '26	-$0.01	-$0.07	-449.02%	MISSED
Q1 '26	-$0.05	-$0.04	14.29%	BEAT
Q4 '25	-$0.05	$0.04	174.17%	BEAT
Q3 '25	-$0.04	-$0.09	-107.69%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

LAB Earnings

Upcoming Earnings: Q3 '26

Historical Earnings